Physician profile
Robert Glaser
NPI 1336164094
$3,306.91
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,169 · 2020: $895 · 2021: $1,066 · 2022: $176.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $520.66 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $414.07 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $345.92 | 2019-2021 | |
| Amgen INC. | $328.39 | 2019-2022 | |
| Pfizer INC. | $320.96 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $283.53 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $261.92 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $241.86 | 2019-2022 | |
| Novo Nordisk INC | $99.22 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $74.13 | 2019-2022 | |
| Abbott Laboratories | $70.42 | 2019-2020 | |
| Insulet Corporation | $67.83 | 2019-2021 | |
| Amarin Pharma, INC. | $65.79 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.24 | 2021 | |
| Biotronik INC. | $37.87 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $35.02 | 2019-2022 | |
| Lilly USA, LLC | $24.52 | 2021 | |
| Boston Scientific Corporation | $21.14 | 2019 | |
| Abbvie INC. | $19.80 | 2021 | |
| Allergan, INC. | $14.81 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.81 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Glaser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.